A second wind for lasers?
This article was originally published in Clinica
Coronary stenting has spiked the guns of several interventional devices. Most seriously affected is directional coronary atherectomy. Laser atherectomy has been immune so far and could even see its use increased. It could be an ideal way to prepare complex lesions for stenting but first the problem of collateral damage must be overcome.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.